Does Health research in Africa end in the lab? How can we move from the lab to providing solutions to addressing existing health challenges?
Kenya continues to be involved in conduct of clinical trials for various health technologies. How much of these products are innovated locally? What needs to be done to bring local products to clinical trials?
Where is Kenya in resourcing health research and innovation?
The government of Kenya played a critical leadership role in the final negotiations of the SDGs, which recognise the importance of increased health R&D and domestic financing in ending the epidemics of HIV/AIDs, tuberculosis, malaria and neglected tropical diseases, as well as reducing maternal mortality and ending preventable deaths of new-borns and children. With increased domestic violence in R&D- leading to the development of new health technologies like drugs, vaccines, devices and diagnostics- and robust accountability mechanisms, Kenya can more quickly move toward these ambitious health-related targets and improve the health and well-being of its people.
Longstanding partnerships and innovation improve health for millions such as one with PATH.
PATH’s broad reach in Kenya allows to identify, implement, and evaluate solutions at a very large scale. For example, the AIDS Population Health Integrated Assistance (APHIAplus) Western project, which they lead, works with more than 800 public and private health facilities, local organizations and communities, governments, health workers, and volunteers. Together they strengthen services for HIV; tuberculosis (TB); malaria; maternal, newborn, and child health; nutrition; and reproductive health. Together, these activities are strengthening the entire health system.
They are expanding their work to address the rising burden of non-communicable diseases in Kenya.
HIV and TB: PATH is strengthening local and country systems to respond to HIV and TB by training health workers to improve prevention, screening, and care and working with communities to reduce stigma, improve community-based services, and support orphans and vulnerable children. Their creative approaches to encouraging healthy behaviors have engaged hundreds of thousands of young Kenyans and members of other hard-to-reach communities, including sex workers and uniformed personnel.
Malaria: PATH system and service innovations, including digital health, are strengthening disease surveillance and case management. MalariaCare, a global partnership led by PATH, is strengthening health workers’ ability to use appropriate diagnostic technologies. Working with Kenyan scientists and health authorities, PATH’s Malaria Vaccine Initiative is advancing efforts to develop safe and effective vaccines against malaria.
Women’s and children’s health: PATH strengthens systems and mobilizes communities to improve and integrate services for family planning, reproductive health, and maternal, newborn, and child health; supports access to lifesaving immunizations; and introduces technologies that can save the lives of mothers and children. We work to ensure that Kenya’s infants, children, and pregnant women have access to the nutrition they need. To address diarrheal disease they advance new vaccines; help caregivers access lifesaving treatment; and improve water, sanitation, and hygiene.
Advocacy and policy: PATH works with decision-makers to encourage investments and policies that bring health within reach for women, infants, and children. They also build the capacity of Kenyan advocates. In addition, they help to strengthen research and development to support locally developed health solutions.
More on PATH at http://www.path.org/our-work/kenya.php
Attached: APP_chread_launch_fs LAUNCH OF THE COALITION FOR HEALTH RESEARCH AND DEVELOPMENT